Nadler has asked for a meeting with DOJ five times over the past six weeks House Judiciary Committee Chairman Jerrold Nadler (D-NY) released the following statement in response to the Department of Justice’s (DOJ) request to meet on Wednesday, the day the Committee is scheduled to markup a contempt citation for Attorney General William Barr’s failure to comply with a subpoena for the full, unredac... Read more »
Today, the House Judiciary Committee noticed a markup of a contempt report for Attorney General William Barr’s failure to comply with a duly issued subpoena to provide Congress with the full, unredacted version of Special Counsel Robert Mueller’s report along with underlying evidence. The contempt markup is scheduled to take place on Wednesday, May 8, 2019 at 10 a.m. During the markup, Committee M... Read more »
Watch Here Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on the Constitution, Civil Rights, and Civil Liberties field hearing on voting rights in Houston, Texas: “Thank you, Chairman Cohen, for calling this important field hearing. The Voting Rights Act of 1965 is considered by most civil rights advocates the most effe... Read more »
Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) sent a letter to Attorney General William Barr with a counter offer to immediately gain access to the redacted portions of Special Counsel Mueller’s report and underlying materials. In the Judiciary Committee Counter Offer: Nadler requests that the Department reconsider its refusal to allow all Members of Congress and appropriate staf... Read more »
House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks today at a hearing where Attorney General William Barr refused to testify: “Attorney General Barr has informed us that he will not appear today. Although we worked to accommodate his concerns, he objects to the prospect of answering questions by staff counsel and to the possibility that we may go into ... Read more »
Washington, D.C. – Today, House Judiciary Chairman Jerrold Nadler (D-NY) delivered the following opening remarks for the first ever markup of H.R. 5, the Equality Act, which explicitly prohibits discrimination against the LGBTQ community: “Today, the Judiciary Committee considers H.R. 5, the ‘Equality Act.’ This is long-overdue legislation that will explicitly prohibit discrimination against lesb... Read more »
Washington, D.C. – Today, House Judiciary Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, for the markup on the motion to permit Committee staff to question Attorney General William Barr following the end of Member questioning at tomorrow's oversight hearing of the Department of Justice: "This motion is similar to my previous motion, differing only in that i... Read more »
Today, the House Judiciary Committee unanimously passed four bills to address prescription drug pricing, including H.R. 965, the CREATES Act; H.R. 2375, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 2374, the Stop STALLING Act; and H.R. 2376, the Prescription Pricing for the People Act of 2019. This markup is part of the first phase of the Committee’s agenda to lower the soa... Read more »
Washington, D.C. (April 30, 2019) – Today, Representatives Elijah E. Cummings (D-MD), Chairman of the Committee on Oversight and Reform; Jerrold Nadler (D-NY), Chairman of the House Committee on the Judiciary; and Karen Bass (D-CA), Chairwoman of the Subcommittee on Crime, Terrorism and Homeland Security; reintroduced the Record Expungement Designed to Enhance Employment (REDEEM) Act on the last d... Read more »
Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the markup of H.R. 2374, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (Stop STALLING Act): “H.R. 2374, the ‘Stop STALLING Act,’ takes an important step toward lowering drug prices and increasing competition in health care markets. It does t... Read more »
